Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Listing Regulations’) read with part A of Schedule III of the Listing Regulations, Gujarat Themis Biosyn has informed that the management of the Company had calls/meetings with Analysts/Investors on Monday, 26th September, 2022; the details of the same are enclosed. No Unpublished Price Sensitive Information (UPSI) was discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company: www.gtbl.in
The above information is a part of company’s filings submitted to BSE.
